Synthesis and biological evaluation of benzimidazole–oxindole conjugates as microtubule-targeting agents
-
Add time:08/18/2019 Source:sciencedirect.com
A series of benzimidazole–oxindole conjugates were synthesized and evaluated for their cytotoxic activity. The cytotoxicity assay results suggest that conjugates 5c and 5p exhibit promising cytotoxicity against human breast cancer cell line (MCF-7). The Cell cycle analysis revealed that these conjugates induced cell cycle arrest at G2/M phase in MCF-7 cells. The tubulin polymerization assay results suggested that these conjugates inhibit tubulin polymerization with IC50 values 1.12 and 1.59 μM respectively. Immunofluorescence analysis also suggested that these conjugates effectively inhibited the microtubule assembly in MCF-7 cells. Further, molecular docking studies indicated that these conjugates 5c and 5p interact and binds efficiently with the tubulin protein. By and large, the results demonstrated that these benzimidazole–oxindole conjugates possess cytotoxic property by inhibiting the tubulin polymerization.
We also recommend Trading Suppliers and Manufacturers of 1-(2',6'-difluorophenyl)-1H,3H-thiazolo(3,4-a)benzimidazole (cas 138226-12-7). Pls Click Website Link as below: cas 138226-12-7 suppliers
Prev:Synthesis of [11C]palmitic acid for PET imaging using a single molecular sieve 13X cartridge for reagent trapping, radiolabeling and selective purification
Next:Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Structural investigation of HIV-1 nonnucleoside reverse transcriptase inhibitors: 2-Aryl-substituted benzimidazoles08/21/2019
- Original articleTheoretical studies on benzimidazole and imidazo[1,2-a]pyridine derivatives as Polo-like kinase 1 (Plk1) inhibitors: Pharmacophore modeling, atom-based 3D-QSAR and molecular docking approach08/20/2019
- Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents08/19/2019


